Wed.Aug 08, 2018

article thumbnail

New Insights in the Cannabis Genome will Be Shared at CannMed 2018

Medicinal Genomics

Thanks to funding from the DASH network, Medicinal Genomics is currently working on a project to create a more complete cannabis reference genome. Medicinal Genomics was the first company to sequence the cannabis genome in 2011, but the limitations in sequencing technology left some of the genetic information incomplete. Fast forward to 2018 and Pacific Biosciences now has tools that can sequence 20,000-100,000 base pair reads with single molecule sequencing.